WST PE Ratio & Valuation, Is WST Overvalued

Historical Valuation

West Pharmaceutical Services Inc (WST) is now in the Undervalued zone, suggesting that its current forward PE ratio of 36.97 is considered Undervalued compared with the five-year average of 42.61. The fair price of West Pharmaceutical Services Inc (WST) is between 242.58 to 315.23 according to relative valuation method. Compared to the current price of 233.83 USD , West Pharmaceutical Services Inc By Undervalued By 3.61%.

Relative Value

Fair Zone

242.58-315.23

Current Price：233.83

3.61%

Undervalued

P/E

EV/EBITDA

EV/EBIT

P/S

P/OCF

P/FCF

Trailing

Forward

Unlock 5-Year Valuation Change

Is West Pharmaceutical Services Inc (WST) at a historical peak or a rare bargain? Access the full 5-year trend to find out.

Unlock Now

West Pharmaceutical Services Inc (WST) has a current Price-to-Book (P/B) ratio of 6.51. Compared to its 3-year average P/B ratio of 8.29, the current P/B ratio is approximately -21.43% higher. Relative to its 5-year average P/B ratio of 9.58, the current P/B ratio is about -32.01% higher. West Pharmaceutical Services Inc (WST) has a Forward Free Cash Flow (FCF) yield of approximately 1.91%. Compared to its 3-year average FCF yield of 1.63%, the current FCF yield is approximately 17.20% lower. Relative to its 5-year average FCF yield of 1.57%, the current FCF yield is about 21.29% lower.

Competitors Valuation Multiple

AI Analysis

The average P/S ratio for WST competitors is 4.79, providing a benchmark for relative valuation. West Pharmaceutical Services Inc Corp (WST.N) exhibits a P/S ratio of 6.20, which is 29.56% above the industry average. Given its robust revenue growth of 7.51%, this premium appears unsustainable.

P/E

P/S

EV/EBITDA

EV/EBIT

Earnings Growth

Market Cap

Performance Decomposition

AI Analysis

Market capitalization of WST increased by 0.00% over the past 1 year(s). The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.

The secondary factor is the Unknown, contributed 0.00% to the performance.

Overall, the performance of WST in the past 1 year(s) is driven by Unknown.

People Also Watch

Frequently Asked Questions

Is WST currently overvalued or undervalued?

West Pharmaceutical Services Inc (WST) is now in the Undervalued zone, suggesting that its current forward PE ratio of 36.97 is considered Undervalued compared with the five-year average of 42.61. The fair price of West Pharmaceutical Services Inc (WST) is between 242.58 to 315.23 according to relative valuation method. Compared to the current price of 233.83 USD, West Pharmaceutical Services Inc is Undervalued By 3.61%.

What is West Pharmaceutical Services Inc (WST) fair value?

WST's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. The fair price of West Pharmaceutical Services Inc (WST) is between 242.58 to 315.23 according to relative valuation method.

How does WST's valuation metrics compare to the industry average?

The average P/S ratio for WST's competitors is 4.79, providing a benchmark for relative valuation. West Pharmaceutical Services Inc Corp (WST) exhibits a P/S ratio of 6.20, which is 29.56% above the industry average. Given its robust revenue growth of 7.51%, this premium appears unsustainable.

What is the current P/B ratio for West Pharmaceutical Services Inc (WST) as of Mar 11 2026?

As of Mar 11 2026, West Pharmaceutical Services Inc (WST) has a P/B ratio of 6.51. This indicates that the market values WST at 6.51 times its book value.

What is the current FCF Yield for West Pharmaceutical Services Inc (WST) as of Mar 11 2026?

As of Mar 11 2026, West Pharmaceutical Services Inc (WST) has a FCF Yield of 1.91%. This means that for every dollar of West Pharmaceutical Services Inc's market capitalization, the company generates 1.91 cents in free cash flow.

What is the current Forward P/E ratio for West Pharmaceutical Services Inc (WST) as of Mar 11 2026?

As of Mar 11 2026, West Pharmaceutical Services Inc (WST) has a Forward P/E ratio of 36.97. This means the market is willing to pay $36.97 for every dollar of West Pharmaceutical Services Inc's expected earnings over the next 12 months.

What is the current Forward P/S ratio for West Pharmaceutical Services Inc (WST) as of Mar 11 2026?

As of Mar 11 2026, West Pharmaceutical Services Inc (WST) has a Forward P/S ratio of 6.20. This means the market is valuing WST at $6.20 for every dollar of expected revenue over the next 12 months.

WST Valuation